Trodelvy® for the Treatment of Metastatic Urothelial Cancer
The Pharma Data
APRIL 14, 2021
Tagawa, MD, MS, FACP, Professor of Medicine and Urology at Weill Cornell Medicine, an oncologist at New York-Presbyterian/Weill Cornell Medical Center and principal investigator of the TROPHY study. Canada, Switzerland and Australia, as well as in Singapore through our partner Everest Medicines. About Trodelvy.
52 
Let's personalize your content